Endpoint Adjudication Best Practices: What Top Teams Do Differently

By Cathy Tyner, Head of Clinical Strategy

Clinical trial endpoint adjudication is critical for subjective data, yet the lack of standard regulatory guidance leaves many teams building processes from scratch. This improvised approach risks delayed milestones, high rates of rework, and compromised data integrity. To protect trial outcomes, sponsors must design their adjudication strategy by working backward from the statistical analysis plan. This ensures that the data capture plan, committee roster, and system architecture are fully aligned long before the first patient is enrolled.

A successful workflow relies on finalizing a comprehensive committee charter before deploying any technical software. Prioritizing the charter eliminates the cascading costs of system rework, while leaning on focused source dossiers accelerates case closure. Furthermore, teams can elevate data quality by replacing blind, "majority-wins" tiebreakers with true arbitration workflows that analyze the root cause of discordant assessments. By abandoning manual spreadsheets in favor of integrated digital workspaces, study teams gain real-time collaboration and automated guardrails that keep critical trials on time, on budget, and ready for regulatory scrutiny.